Newsfeeds - Spark Newswire

1 minute read

News

Hepion Pharmaceuticals Announces Postponement of 2021 Annual Meeting Of Stockholders; No Future Date Has Been Set

Today, 5:58 AM

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis

HEPA

5 minute read

Uncategorized

The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts

By Shanthi Rexaline

Today, 5:58 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13)

ACHL

6 minute read

98 Biotechnology Stocks Moving In Wednesday’s Session

By Benzinga Newsdesk

Today, 5:58 AM

Gainers • Neurotrope, Inc. (NASDAQ:NTRP) stock increased by 131.7% to $3.36 during Wednesday’s regular session. • Genprex, Inc.…

ACRS

7 minute read

116 Healthcare Stocks Moving In Wednesday’s Session

By Benzinga Newsdesk

Today, 5:58 AM

Gainers • Neurotrope, Inc. (NASDAQ:NTRP) stock moved upwards by 133.1% to $3.38 during Wednesday’s regular session. • Genprex,…

ACRS

Latest news

Hepion Pharmaceuticals Announces Postponement of 2021 Annual Meeting Of Stockholders; No Future Date Has Been Set

The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts

98 Biotechnology Stocks Moving In Wednesday’s Session

116 Healthcare Stocks Moving In Wednesday’s Session